Metraipolis › archive › dc_7cda21ecc63c

Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42405441
DOI
10.1111/ene.70698
License (as archived)
solo-consultazione
Archived
2026-10-18T12:25:43.886Z
SHA-256 of the archived text
cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8
Stable URL of this page
https://metraipolis.com/documento/dc_7cda21ecc63c

How to cite

Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441 — Europe PMC (en), https://europepmc.org/article/MED/42405441 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cda21ecc63c (Metraipolis archive dc_7cda21ecc63c, sha256 cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8)
BibTeX
@misc{dc7cda21ecc63c,
  title = {Transfusion-Associated Graft-Versus-Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy? — Europe PMC PMID:42405441},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42405441},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cda21ecc63c; sha256 cdd4f018234203ea0e61da667ff5efa3fb7a06b5f21c076bf506e757636b26b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42405441. Agents can read the archived copy with the MCP tool read_document.